Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Insulin up-regulates natriuretic peptide clearance receptor expression in the subcutaneous fat depot in obese subjects: a missing link between CVD risk and obesity?
Pivovarova O, Gögebakan Ö, Klöting N, Sparwasser A, Weickert MO, Haddad I, Nikiforova VJ, Bergmann A, Kruse M, Seltmann AC, Blüher M, Pfeiffer AF, Rudovich N. Pivovarova O, et al. Among authors: sparwasser a. J Clin Endocrinol Metab. 2012 May;97(5):E731-9. doi: 10.1210/jc.2011-2839. Epub 2012 Mar 14. J Clin Endocrinol Metab. 2012. PMID: 22419733 Clinical Trial.
Acarbose treatment enhances mid-regional pro-atrial natriuretic peptide concentrations in non-diabetic individuals: further evidence for a common cardiometabolic pathway?
Rudovich N, Pivovarova O, Traberth A, Sparwasser A, Weickert MO, Bernigau W, Birkenfeld AL, Arafat AM, Bergmann A, Pfeiffer AF. Rudovich N, et al. Among authors: sparwasser a. Diabetologia. 2012 Dec;55(12):3392-5. doi: 10.1007/s00125-012-2724-9. Epub 2012 Sep 20. Diabetologia. 2012. PMID: 22990716 Clinical Trial. No abstract available.
Effect of exogenous intravenous administrations of GLP-1 and/or GIP on circulating pro-atrial natriuretic peptide in subjects with different stages of glucose tolerance.
Rudovich N, Pivovarova O, Gögebakan Ö, Sparwasser A, Doehner W, Anker SD, Arafat AM, Bergmann A, Nauck MA, Pfeiffer AF. Rudovich N, et al. Among authors: sparwasser a. Diabetes Care. 2015 Jan;38(1):e7-8. doi: 10.2337/dc14-1452. Diabetes Care. 2015. PMID: 25538323 Clinical Trial. No abstract available.
Modulation of circulating vasoactive peptides and extracellular matrix proteins are two novel mechanisms in the cardioprotective action of acarbose.
Rudovich N, Pivovarova O, Bernigau W, Sparwasser A, Tacke C, Murahovshi V, Mertes G, Birkenfeld AL, Bergmann A, Weickert MO, Pfeiffer AF. Rudovich N, et al. Among authors: sparwasser a. Minerva Endocrinol. 2016 Dec;41(4):456-68. Epub 2016 Mar 23. Minerva Endocrinol. 2016. PMID: 27007919 Free article. Clinical Trial.
Sandwich Immunoassay for Bioactive Plasma Adrenomedullin.
Weber J, Sachse J, Bergmann S, Sparwaßer A, Struck J, Bergmann A. Weber J, et al. Among authors: sparwasser a. J Appl Lab Med. 2017 Sep 1;2(2):222-233. doi: 10.1373/jalm.2017.023655. J Appl Lab Med. 2017. PMID: 32630976
Analytical performance of an immunoassay to measure proenkephalin.
Donato LJ, Meeusen JW, Lieske JC, Bergmann D, Sparwaßer A, Jaffe AS. Donato LJ, et al. Among authors: sparwasser a. Clin Biochem. 2018 Aug;58:72-77. doi: 10.1016/j.clinbiochem.2018.05.010. Epub 2018 May 18. Clin Biochem. 2018. PMID: 29782819